4.7 Review

Causes, consequences, and treatment of osteoporosis in men

期刊

DRUG DESIGN DEVELOPMENT AND THERAPY
卷 7, 期 -, 页码 849-860

出版社

DOVE MEDICAL PRESS LTD
DOI: 10.2147/DDDT.S46101

关键词

risk factors; hormones; bisphosphonates; nutritional supplements; antibodies; protein inhibitors; male osteoporosis

向作者/读者索取更多资源

Men undergo gradual bone loss with aging, resulting in fragile bones. It is estimated that one in five men will suffer an osteoporotic fracture during their lifetime. The prognosis for men after a hip fracture is very grim. A major cause is reduction of free testosterone. Many other factors result in secondary osteoporosis, including treatment for other diseases such as cancer and diabetes. Patients should be screened not only for bone density but also assessed for their nutritional status, physical activity, and drug intake. Therapy should be chosen based on the type of osteoporosis. Available therapies include testosterone replacement, bisphosphonates, and nutritional supplementation with calcium, vitamin D, fatty acids, and isoflavones, as well as certain specific antibodies, like denosumab and odanacatib, and inhibitors of certain proteins.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据